Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Oct;45(10):800–808. doi: 10.1136/ard.45.10.800

Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response.

P M Houtman, C G Kallenberg, P C Limburg, M A van Leeuwen, M H van Rijswijk, T H The
PMCID: PMC1002000  PMID: 3491585

Abstract

In a follow up study of 11 patients with mixed connective tissue disease the levels of antibodies to nuclear ribonucleoprotein (nRNP) as measured by an enzyme linked immunosorbent assay (ELISA) were related to clinical activity of disease. To assess the relation between anti-nRNP levels and disease activity the levels of total immunoglobulin G, IgM rheumatoid factor (IgM RF), and antibodies to an unrelated antigen (tetanus toxoid) were determined simultaneously. No significant changes in anti-nRNP levels were noted in four patients with minor activity of disease. Major flares of disease were observed in seven patients. Clinical symptoms were preceded by a rise in anti-nRNP level in these patients unless they received immunosuppressive agents before the exacerbation. Conversely, when a rise in anti-nRNP level occurred a major flare of disease was followed in all but one case. Anti-nRNP levels fell during clinical improvement whether or not immunosuppressive treatment was given. All patients showed parallel fluctuations in anti-nRNP, IgM RF, and total immunoglobulin G levels. Furthermore, parallel fluctuations were seen in the levels of anti-nRNP and antibodies to tetanus toxoid except in one patient. We conclude that measurement of anti-nRNP by ELISA may be a guide for disease activity in connective tissue disease. Fluctuations of anti-nRNP are not restricted to this antibody, however, but are part of a more polyclonal activity of the B lymphocyte system.

Full text

PDF
800

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcon-Segovia D., Ruiz-Arguelles A., Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature. 1978 Jan 5;271(5640):67–69. doi: 10.1038/271067a0. [DOI] [PubMed] [Google Scholar]
  2. Alarcon-Segovia D., Ruiz-Arguelles A., Llorente L. Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol. 1979 May;122(5):1855–1862. [PubMed] [Google Scholar]
  3. Gilliam J. N., Prystowsky S. D. Mixed connective tissue disease syndrome. Arch Dermatol. 1977 May;113(5):583–587. [PubMed] [Google Scholar]
  4. Houtman P. M., Kallenberg C. G., Limburg P. C., Huitema M. G., van Rijswijk M. H., The T. H. Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. Clin Exp Immunol. 1985 Dec;62(3):696–704. [PMC free article] [PubMed] [Google Scholar]
  5. Hurd E. R., Dowdle W., Casey H., Ziff M. Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum. 1972 May-Jun;15(3):267–274. doi: 10.1002/art.1780150308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Izuno G. T. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells. Br J Dermatol. 1978 Apr;98(4):391–398. doi: 10.1111/j.1365-2133.1978.tb06531.x. [DOI] [PubMed] [Google Scholar]
  7. Kallenberg C. G., Limburg P. C., Van Slochteren C., Van der Woude F. J., The T. H. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol. 1983 Aug;53(2):371–383. [PMC free article] [PubMed] [Google Scholar]
  8. Lerner M. R., Boyle J. A., Mount S. M., Wolin S. L., Steitz J. A. Are snRNPs involved in splicing? Nature. 1980 Jan 10;283(5743):220–224. doi: 10.1038/283220a0. [DOI] [PubMed] [Google Scholar]
  9. Moore T. L., Weiss T. D., Neucks S. H., Baldassare A. R., Zuckner J. Extractable nuclear antigens. Semin Arthritis Rheum. 1981 May;10(4):309–318. doi: 10.1016/0049-0172(81)90007-x. [DOI] [PubMed] [Google Scholar]
  10. Phillips P. E., Christian C. L. Virus antibodies in systemic lupus erythematosus and other connective tissue diseases. Ann Rheum Dis. 1973 Sep;32(5):450–456. doi: 10.1136/ard.32.5.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Reichlin M. Problems in differentiating SLE and mixed connective-tissue disease. N Engl J Med. 1976 Nov 18;295(21):1194–1195. doi: 10.1056/NEJM197611182952112. [DOI] [PubMed] [Google Scholar]
  12. Swaak A. J., Aarden L. A., Statius van Eps L. W., Feltkamp T. E. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 1979 Mar;22(3):226–235. doi: 10.1002/art.1780220304. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES